Share this Job

Assistant Inhalation Data Processor 1

Req ID:  44611
Location: 

Tranent, SCT, GB

For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.

 

 

Assistant Inhalation Data Processor

This vacancy now exists within Inhalation Science (OA36)

Job Role

The role duties include:

  • Assist in the management and processing of Inhalation study data
  • Set up of electronic data systems for Inhalation toxicology studies
  • Quality Control checking of Inhalation data and reports to Good Laboratory Practice (GLP) standards
  • Assisting with continuous improvement initiatives associated with the recording and processing of data
  • Processing QA Audit actions relating to Inhalation study data

The ideal candidate should have some of the following features:

  • Have a basic grasp of scientific principals and appreciation of working precisely
  • Good documentation standards and is organised/works efficiently
  • Works equally well on their own tasks, while is an effective team player when required
  • Good IT skills in that candidates should be able to use MS Word/Excel in a basic capacity
  • Good attendance and punctuality

Full training will be given for the role and there are regular opportunities to develop your skills.

Departmental Info

Inhalation Science is a progressive and close-knit team, working on the challenges of lung delivery of new drugs and agrochemicals, to test their pulmonary toxicity. We actively develop our people, are striving to continuously improve and perpetually advance our understanding/capabilities in this technically challenging field.

 

This position is a scale 2/3. Salary banding for this position is £17,030 dependent on experience.  Successful candidates will be appointed to the bottom of the pay band if they have no relevant experience.

In exceptional circumstances where the candidate has relevant equivalent experience, this will be taken into consideration.

CLOSING DATE : 01 August 2019

 

About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market.  Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.

About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

With over 11,000 employees within 70 facilities in 18 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges.  Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2016, revenue increased by 23.3% to $1.68 billion from $1.36 billion in 2015.

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~70% of the drugs approved by the FDA in 2016.

For more information, please visit www.criver.com.